Agonist-induced changes in the phosphorylation of the myosin- binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle
- PMID: 12296769
- PMCID: PMC1223061
- DOI: 10.1042/BJ20021040
Agonist-induced changes in the phosphorylation of the myosin- binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle
Abstract
The inhibition of myosin light chain phosphatase (MLCP) enhances smooth muscle contraction at a constant [Ca2+]. There are two components, myosin-binding subunit of MLCP (MBS) and CPI17, thought to be responsible for the inhibition of MLCP by external stimuli. The phosphorylation of MBS at Thr-641 and of CPI17 at Thr-38 inhibits the MLCP activity in vitro. Here we determined the changes in the phosphorylation of MBS and CPI17 after agonist stimulation in intact as well as permeabilized smooth muscle strips using phosphorylation-site-specific antibodies as probes. The CPI17 phosphorylation transiently increased after agonist stimulation in both alpha-toxin skinned and intact fibres. The time course of the increase in CPI17 phosphorylation after stimulation correlated with the increase in myosin regulatory light chain (MLC) phosphorylation. The increase in CPI17 phosphorylation was significantly diminished by Y27632, a Rho kinase inhibitor, and GF109203x, a protein kinase C inhibitor, suggesting that both the protein kinase C and Rho kinase pathways influence the change in CPI17 phosphorylation. On the other hand, a significant level of MBS phosphorylation at Thr-641, an inhibitory site, was observed in the resting state for both skinned and intact fibres and the agonist stimulation did not significantly alter the MBS phosphorylation level at Thr-641. While the removal of the agonist markedly decreased MLC phosphorylation and induced relaxation, the phosphorylation of MBS was unchanged, while CPI17 phosphorylation markedly diminished. These results strongly suggest that the phosphorylation of CPI17 plays a more significant role in the agonist-induced increase in myosin phosphorylation and contraction of smooth muscle than MBS phosphorylation in the Ca2+-independent activation mechanism of smooth muscle contraction.
Similar articles
-
Phosphorylation of CPI17 and myosin binding subunit of type 1 protein phosphatase by p21-activated kinase.Biochem Biophys Res Commun. 2002 Oct 4;297(4):773-8. doi: 10.1016/s0006-291x(02)02302-1. Biochem Biophys Res Commun. 2002. PMID: 12359219
-
Dephosphorylation of the two regulatory components of myosin phosphatase, MBS and CPI17.FEBS Lett. 2002 Mar 27;515(1-3):127-32. doi: 10.1016/s0014-5793(02)02451-1. FEBS Lett. 2002. PMID: 11943207
-
cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase.Circ Res. 2007 Sep 28;101(7):712-22. doi: 10.1161/CIRCRESAHA.107.153981. Epub 2007 Aug 2. Circ Res. 2007. PMID: 17673671
-
The regulation of smooth muscle contractility by zipper-interacting protein kinase.Can J Physiol Pharmacol. 2007 Jan;85(1):79-87. doi: 10.1139/y06-103. Can J Physiol Pharmacol. 2007. PMID: 17487247 Review.
-
Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II.J Physiol. 2000 Jan 15;522 Pt 2(Pt 2):177-85. doi: 10.1111/j.1469-7793.2000.t01-2-00177.x. J Physiol. 2000. PMID: 10639096 Free PMC article. Review.
Cited by
-
Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697.Biochem J. 2005 Aug 1;389(Pt 3):763-74. doi: 10.1042/BJ20050237. Biochem J. 2005. PMID: 15823093 Free PMC article.
-
Myosin phosphatase: structure, regulation and function.Mol Cell Biochem. 2004 Apr;259(1-2):197-209. doi: 10.1023/b:mcbi.0000021373.14288.00. Mol Cell Biochem. 2004. PMID: 15124925 Review.
-
Regulation of myosin light-chain phosphorylation and its roles in cardiovascular physiology and pathophysiology.Hypertens Res. 2022 Jan;45(1):40-52. doi: 10.1038/s41440-021-00733-y. Epub 2021 Oct 6. Hypertens Res. 2022. PMID: 34616031 Review.
-
ROCKs as therapeutic targets in cardiovascular diseases.Expert Rev Cardiovasc Ther. 2005 May;3(3):441-51. doi: 10.1586/14779072.3.3.441. Expert Rev Cardiovasc Ther. 2005. PMID: 15889972 Free PMC article. Review.
-
Androgens induce nongenomic stimulation of colonic contractile activity through induction of calcium sensitization and phosphorylation of LC20 and CPI-17.Mol Endocrinol. 2010 May;24(5):1007-23. doi: 10.1210/me.2009-0472. Epub 2010 Mar 5. Mol Endocrinol. 2010. PMID: 20207835 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous